Educating Frontline Clinicians to Reduce Missed Opportunities for HBV Screening

Faculty

Su H. Wang, MD, MPH, FACP
Medical Director, Viral Hepatitis Programs and Center for Asian Health
Cooperman Barnabas Medical Center, RJWBarnabas Health
Livingston, NJ
Su H. Wang, MD, MPH, FACP

Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs and the Center for Asian Health at Cooperman Barnabas Medical Center and a member of the RWJBarnabas Health Medical Group. She is Past President of the World Hepatitis Alliance, a non-governmental organization (NGO) committed to viral hepatitis elimination.

Dr. Wang is an internist and has served as primary investigator for a number of viral hepatitis screening and linkage-to-care grants sponsored by the U.S. Centers for Disease Control and Prevention (CDC) and other funders. She has led primary care-based hepatitis B and C programs, community outreach efforts, patient-based advocacy, and community-based research initiatives.

Dr. Wang has served on a number of World Health Organization (WHO) guideline development committees producing “Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy” and “Interim Guidance for Country Validation of Viral Hepatitis Elimination.” She is a member of the American Association for the Study of Liver Diseases (AASLD) and serves on the steering committee for the HBV Special Interest Group and the Viral Hepatitis Elimination Taskforce, and is on the Patient Advisory Group.

She received her medical degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine and Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the CDC at the U.S. Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.

Alyssa Gallipani, PharmD, BCACP
Ambulatory Care Clinical Specialist
Clinical Assistant Professor of Pharmacy Practice
Fairleigh Dickinson University School of Pharmacy & Health Sciences
Florham Park, NJ
Alyssa Gallipani, PharmD, BCACP

Dr. Alyssa Gallipani, PharmD, BCACP, is clinical assistant faculty at Fairleigh Dickinson University. She practices as a clinical ambulatory care pharmacist at RWJBarnabas Health. She is a board-certified ambulatory care pharmacist through the Board of Pharmacy Specialties and completed ambulatory care residency training at the Brooklyn Hospital Center. Dr. Gallipani provides direct patient care in collaboration with primary care providers at Barnabas Health Medical Group. She treats chronic disease states, including viral hepatitis, and works to improve access to and affordability of medications and to reduce the cost of care. She had the pleasure of collaborating with the Center for Asian Health to screen and treat individuals with viral hepatitis and participate in community outreach and clinical care initiatives. She presented at multiple viral hepatitis organizations, including the Hepatitis B Foundation and the Hepatitis B United Summit. Dr. Gallipani precepts advanced pharmacy practice experience (APPE) students and residents to advocate for the role of the pharmacist as future providers. She is honored to be a part of the panel today with other leaders and trail blazers in the profession.

Chelsey Smith, FNP-C
Retail Health Practitioner
Pittsburgh, PA
Chelsey Smith, FNP-C

Chelsey Smith, FNP-C, is a certified Family Nurse Practitioner. She originally attended Shadyside School of Nursing in Pittsburgh, PA, where she received her RN. Chelsey then pursued her interest in nursing, graduating with honors, from Chatham University with a Bachelor of Science in Nursing. While working in the neuroscience intensive care unit stepdown in Pittsburgh and providing pediatric home health care, she completed her Master of Science in Nursing with a specialty in Family. Chelsey is a board-certified Family Nurse Practitioner through AANP and licensed in Pennsylvania. She has worked primarily in a retail health care setting as a nurse practitioner since 2013. She has a passion for community health and for care across the lifespan. When not in the clinic, Chelsey enjoys spending time with her husband and two boys (age 10 and 13), gardening, and traveling.

Statement of Need

Hepatitis B virus (HBV) is one of the leading causes of chronic liver disease, cirrhosis, and liver cancer in the United States, but HBV screening opportunities are often missed due to the bias, stigma, or knowledge deficits of health care professionals (HCPs) and the lack of linkage to care. Front-line HCPs, particularly in community-based settings, need education on universal screening practices as well as a multi-faceted approach for streamlining linkage to care, including cultural humility training to overcome barriers related to social determinants of health (SDoH).

In this recorded CME Outfitters webcast, expert faculty focus on universal HBV screening with triple panel testing to accurately identify patients with active HBV infection. The faculty also present strategies and best practices for linking patients with HBV to appropriate medical care based on interpretation of serological test results while factoring in SDoH.

Learning Objectives

  • Implement universal HBV screening with triple panel testing to accurately identify patients with active HBV infection.
  • Link patients with HBV infection to appropriate medical care based on interpretation of serological test results.

Financial Support

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Target Audience

Primary care practitioners, physician associates (PAs,) nurse practitioners (NPs), nurses, pharmacists, and ER clinicians

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-23-019-H01-P

Physician Assistants (AAPA): 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.


Dr. Wang reports the following financial relationships: Grants: Gilead Sciences, Inc. (FOCUS grant to institution)


Dr. Gallipani reports no financial relationships to disclose.


Ms. Smith reports no financial relationships to disclose.


The following peer reviewer and CME Outfitters staff report no financial relationships:

  • Joshua Caballero, PharmD, BCPP, FCCP (peer reviewer)
  • Susan Perry (planning committee)
  • Kellie Busby, PharmD (planning committee)
  • John Jones, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WCV-064-032323-47

Educating Frontline Clinicians to Reduce Missed Opportunities for HBV Screening
Event Date: 03/23/2023 at 4:00 am EST